Special issues
Endocrine-Related Cancer publishes regular anniversary issues to mark the most significant historical advances in the field. These contain an editorial from the invited guest editor(s) and a collection of thematic reviews.
2021
80 Years of the Use of Radioiodine (October 2021). Guest edited by Christopher John McCabe.
80 Years of Androgen Deprivation as a Treatment for Prostate Cancer (August 2021). Guest edited by Amina Zoubeidi and Paramita Ghosh.
2020
Hereditary endocrine tumours: Current state-of-the-art and research opportunities (August 2020). Guest edited by Steven Waguespack and Constantine Stratakis.
2018
65 Years of the Double Helix (August 2018). Guest edited by William D Foulkes, Jérôme Bertherat and Charis Eng.
25 Years of RET and MEN 2 (February 2018). Guest edited by Frank Weber and Lois M Mulligan.
2017
Immunotherapy and cancer (December 2017). Guest edited by Joanne Y Y Ngeow and Laura S Ward.
20 Years of MEN 1 (October 2017). Guest edited by Frank Weber and Lois M Mulligan.
Celebrating 50yrs of Tubulin & Cancer (September 2017). Guest edited by Karen Crasta and Ritu Aneja.
2016
Contemporary perspectives in hormone-dependent cancers (December 2016). Guest edited by Wayne D Tilley.
Celebrating women in cancer research (November 2016). Guest edited Deborah J Marsh and Charis Eng.
20 Years of BRCA1 and 2 (October 2016). Guest edited by William D Foulkes and Kokichi Sugano.
2015
Thematic reviews on stem cells and cancer (December 2015). Guest edited by Dean G Tang.
15 Years of Paraganglioma (August 2015). Guest edited by Hartmut P H Neumann and Wouter de Herder.
Thematic reviews on ubiquitination and cancer (February 2015). Guest edited by Deborah J Marsh.
2014
New concepts and challenges in thyroid cancer (October 2014). Guest edited by Laura Sterian Ward.
Thematic reviews on androgens and the AR in breast and prostate cancer (August 2014). Guest edited by Frank Claessens and Wayne Tilley.
Thematic reviews on endocrine disruptors and cancer (April 2014). Guest edited by Gail P Risbridger.